ESSA Pharma Inc.
EPIX
$0.2456
-$0.0175-6.65%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 109.62M | 113.87M | 120.55M | 126.76M | 130.69M |
| Total Receivables | 527.10K | 415.50K | 154.40K | 163.00K | 183.60K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 337.40K | 656.60K | 1.21M | 301.80K | 906.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 17.80K | 222.90K | 186.20K | 334.60K | 306.60K |
| Total Current Assets | 110.50M | 115.17M | 122.11M | 127.56M | 132.09M |
|
|
|||||
| Total Current Assets | 110.50M | 115.17M | 122.11M | 127.56M | 132.09M |
| Net Property, Plant & Equipment | -- | 248.00K | 272.10K | 295.50K | 318.30K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | 257.00K | 257.00K | 257.00K |
| Total Assets | 110.50M | 115.42M | 122.63M | 128.11M | 132.67M |
|
|
|||||
| Total Accounts Payable | 971.40K | 864.20K | 1.84M | 2.40M | 1.91M |
| Total Accrued Expenses | 628.60K | 724.60K | 1.73M | 773.50K | 1.55M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 125.90K | 125.00K | 124.10K | 112.40K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.60M | 1.71M | 3.69M | 3.30M | 3.58M |
|
|
|||||
| Total Current Liabilities | 1.60M | 1.71M | 3.69M | 3.30M | 3.58M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 154.30K | 180.10K | 205.20K | 229.70K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.60M | 1.87M | 3.87M | 3.51M | 3.80M |
|
|
|||||
| Common Stock & APIC | 337.91M | 338.55M | 337.38M | 334.67M | 332.61M |
| Retained Earnings | -226.91M | -222.91M | -216.54M | -208.00M | -201.65M |
| Treasury Stock & Other | -2.10M | -2.09M | -2.07M | -2.06M | -2.10M |
| Total Common Equity | 108.90M | 113.55M | 118.77M | 124.61M | 128.86M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 108.90M | 113.55M | 118.77M | 124.61M | 128.86M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 108.90M | 113.55M | 118.77M | 124.61M | 128.86M |
|
|
|||||